Table 3 Height outcomes at 14 days and 6 months
From: Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial
|  | 14 Days | 6 Months | ||||||
|---|---|---|---|---|---|---|---|---|
| Â | Azithromycin Mean (SD) | Placebo Mean (SD) | Mean Difference or Odds Ratioa (95% CI) | P-value | Azithromycin Mean (SD) | Placebo Mean (SD) | Mean Difference or Odds Ratioa (95% CI) | P-value |
Height change, mm/day | 0.8 (1.7) | 0.5 (2.3) | 0.3 (−0.07 to 0.7) | 0.11 | 0.4 (0.2) | 0.3 (0.2) | 0.02 (−0.02 to 0.06) | 0.57 |
Height, cm | 86.0 (12.0) | 86.6 (11.5) | 0.3 (−0.1 to 0.7) | 0.15 | 91.6 (11.5) | 91.3 (10.6) | 0.3 (−0.3 to 0.8) | 0.32 |
Height-for-age Z-score | −0.9 (1.1) | −0.8 (1.2) | 0.08 (− 0.04 to 0.2) | 0.21 | − 0.8 (1.1) | −0.7 (1.1) | 0.05 (− 0.1 to 0.2) | 0.55 |
Stunted (HAZ < -2) | 15.1% | 13.2% | 0.7 (0.4 to 1.6) | 0.46 | 11.9% | 10.0% | 1.1 (0.5 to 2.5) | 0.76 |